Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sunshine Biopharma's share price for the quarter that ended in Mar. 2026 was $10.4. Sunshine Biopharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 0.49 Mil. Therefore, Sunshine Biopharma's market cap for the quarter that ended in Mar. 2026 was $5.11 Mil.
Sunshine Biopharma's quarterly market cap
declined
from Sep. 2025 ($6.79 Mil) to Dec. 2025 ($6.04 Mil) and
declined
from Dec. 2025 ($6.04 Mil) to Mar. 2026 ($5.11 Mil).
Sunshine Biopharma's annual market cap
increased
from Dec. 2023 ($5.43 Mil) to Dec. 2024 ($7.74 Mil) but then
declined
from Dec. 2024 ($7.74 Mil) to Dec. 2025 ($6.04 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sunshine Biopharma's Enterprise Value for Today is $-3.37 Mil.
Sunshine Biopharma (NAS:SBFM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sunshine Biopharma Market Cap Related Terms
Sunshine Biopharma Market Cap Historical Data
* Premium members only.
The historical data trend for Sunshine Biopharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Biopharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Sunshine Biopharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sunshine Biopharma's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Biopharma (SBFM) has a Market Cap of $2.78 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunshine Biopharma and its competitors. According to the industry distribution chart, Sunshine Biopharma ranks #956 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 93.4%.
Is Sunshine Biopharma's Market Cap too high?
Sunshine Biopharma's current Market Cap is $2.78 Mil. The Drug Manufacturers industry median Market Cap is 210.64. Sunshine Biopharma's value of $2.78 Mil is 98.7% below this industry median. Based on the distribution chart, Sunshine Biopharma ranks #956 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sunshine Biopharma has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Biopharma's Market Cap compare to PRFX and BUDZ?
According to the Drug Manufacturers industry distribution chart, Sunshine Biopharma ranks #956 out of 1024 companies for Market Cap. This places Sunshine Biopharma in the lower half of its industry. The industry median Market Cap is 210.64. Sunshine Biopharma's value of $2.78 Mil is 98.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.64, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Biopharma's current Market Cap of $2.78 Mil is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunshine Biopharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Biopharma's current Market Cap is $2.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Biopharma (SBFM) is currently considered Possible Value Trap. The stock's GF Value™ is $7.39, compared to a current price of $1.17 — trading 84.2% below its estimated fair value. The current Market Cap is $2.78 Mil and 98.7% below the Drug Manufacturers industry median of 210.64. Sunshine Biopharma's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sunshine Biopharma (SBFM), the current Market Cap is $2.78 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunshine Biopharma (SBFM) Overvalued in 2026?
Based on GuruFocus' analysis, Sunshine Biopharma stock appears to be undervalued.
The current stock price of $1.17 is trading 84.2% below its estimated GF Value™ of $7.39.
GuruFocus considers Sunshine Biopharma to be Possible Value Trap.
Key valuation signals for SBFM:
Market Cap: $2.78 Mil
GF Value™: $7.39 vs. price of $1.17 (84.2% below fair value)
Industry Position: 98.7% below the Drug Manufacturers median (#956 of 1024)
No single metric tells the full story. See the SBFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
34GF Score
Get the complete analysis for SBFM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBFM has been successfully added to your 
